Some clinical implications of the receptor concept.
D000322:Adrenergic Agonists / Q000494:pharmacology; D000787:Angina Pectoris / Q000188:drug therapy; D001249:Asthma / Q000188:drug therapy; D004837:Epinephrine / Q000494:pharmacology; D007217:Indoramin / Q000494:pharmacology; D013948:Moxisylyte / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010437:Peptic Ulcer / Q000188:drug therapy; D010673:Pheochromocytoma / Q000188:drug therapy / Q000209:etiology; D011433:Propranolol / Q000494:pharmacology; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D011955:Receptors, Drug / Q000502:physiology
D000322:Adrenergic Agonists; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D011955:Receptors, Drug; D007217:Indoramin; D011433:Propranolol; D013948:Moxisylyte; D009638:Norepinephrine; D004837:Epinephrine